215 related articles for article (PubMed ID: 32243971)
1. Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol.
Itin C; Barasch D; Domb AJ; Hoffman A
Int J Pharm; 2020 May; 581():119276. PubMed ID: 32243971
[TBL] [Abstract][Full Text] [Related]
2. A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.
Itin C; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2019 Oct; 16(10):1031-1035. PubMed ID: 31393180
[No Abstract] [Full Text] [Related]
3. Prolonged Delivery of Apomorphine Through the Buccal Mucosa, Towards a Noninvasive Sustained Administration Method in Parkinson's Disease: In Vivo Investigations in Pigs.
Itin C; Komargodski R; Barasch D; Domb AJ; Hoffman A
J Pharm Sci; 2021 Apr; 110(4):1824-1833. PubMed ID: 33333142
[TBL] [Abstract][Full Text] [Related]
4. Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies.
Provenzano R; De Caro C; Vitiello A; Izzo L; Ritieni A; Ungaro F; Quaglia F; Russo E; Miro A; d'Angelo I
Drug Deliv Transl Res; 2024 Jun; 14(6):1648-1659. PubMed ID: 38064145
[TBL] [Abstract][Full Text] [Related]
5. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
[TBL] [Abstract][Full Text] [Related]
6. Buccal delivery of methimazole as an alternative means for improvement of drug bioavailability: permeation studies and matrix system design.
De Caro V; Giandalia G; Siragusa MG; Giannola LI
Curr Pharm Des; 2012; 18(34):5405-10. PubMed ID: 22632389
[TBL] [Abstract][Full Text] [Related]
7. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
Zhang H; Zhang J; Streisand JB
Clin Pharmacokinet; 2002; 41(9):661-80. PubMed ID: 12126458
[TBL] [Abstract][Full Text] [Related]
8. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
9. Recent developments of nanoparticle-delivered dosage forms for buccal delivery.
Tran PHL; Duan W; Tran TTD
Int J Pharm; 2019 Nov; 571():118697. PubMed ID: 31526839
[TBL] [Abstract][Full Text] [Related]
10.
Pinto S; Pintado ME; Sarmento B
Expert Opin Drug Deliv; 2020 Jan; 17(1):33-48. PubMed ID: 31786958
[No Abstract] [Full Text] [Related]
11. New developments and opportunities in oral mucosal drug delivery for local and systemic disease.
Hearnden V; Sankar V; Hull K; Juras DV; Greenberg M; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill MH
Adv Drug Deliv Rev; 2012 Jan; 64(1):16-28. PubMed ID: 21371513
[TBL] [Abstract][Full Text] [Related]
12. Human buccal mucosa as an innovative site of drug delivery.
Campisi G; Paderni C; Saccone R; Di Fede O; Wolff A; Giannola LI
Curr Pharm Des; 2010; 16(6):641-52. PubMed ID: 20388074
[TBL] [Abstract][Full Text] [Related]
13. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
Franco V; Gershkovich P; Perucca E; Bialer M
Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
[TBL] [Abstract][Full Text] [Related]
14. Buccal delivery systems.
Hao J; Heng PW
Drug Dev Ind Pharm; 2003 Sep; 29(8):821-32. PubMed ID: 14570303
[TBL] [Abstract][Full Text] [Related]
15. Development of an ex vivo retention model simulating bioadhesion in the oral cavity using human saliva and physiologically relevant irrigation media.
Madsen KD; Sander C; Baldursdottir S; Pedersen AM; Jacobsen J
Int J Pharm; 2013 May; 448(2):373-81. PubMed ID: 23538096
[TBL] [Abstract][Full Text] [Related]
16. Buccoadhesive drug delivery systems--extensive review on recent patents.
Pathan SA; Iqbal Z; Sahani JK; Talegaonkar S; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2008; 2(2):177-88. PubMed ID: 19075906
[TBL] [Abstract][Full Text] [Related]
17. [Drug delivery systems by controlled release].
Nagai T
Yakugaku Zasshi; 1988 Jul; 108(7):613-24. PubMed ID: 3071605
[No Abstract] [Full Text] [Related]
18. Mucoadhesive polymers for oral transmucosal drug delivery: a review.
Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O
Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395
[TBL] [Abstract][Full Text] [Related]
19. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization.
Palem CR; Kumar Battu S; Gannu R; Yamsani VV; Repka MA; Yamsani MR
Pharm Dev Technol; 2012; 17(3):321-32. PubMed ID: 21265709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
